| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8648604 | Molecular Immunology | 2018 | 8 Pages | 
Abstract
												Cell-derived extracellular vesicles (EVs) are involved in the pathogenesis of rheumatoid arthritis (RA), playing important roles in antigen presentation, inflammation, angiogenesis, cell-cell signal communication, thrombosis, and articular cartilage extracellular matrix degradation. Understanding the pathogenic mechanism of RA is important for developing therapies. The pathogenic indicators of RA, such as submicron-sized EVs, represent promising biomarkers for evaluating RA activity. This review summarizes the recent advances in understanding the pathogenesis of RA, and sheds light on the pathogenic as well as anti-inflammatory or immunosuppressive roles of EVs. We suggest that EVs could be harnessed as tools for drug delivery or targets for RA therapies.
											Keywords
												TLRsalicylazosulfapyridineTNF15-LOSASPinhibitor of DNA binding 1CD13MTXFADDNF-κBAPCFLSRANKLMMPMCP15-LipoxygenaseId1Rheumatoid arthritisAminopeptidase NinflammationToll-like receptorRankantigen presenting cellIRAKVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)tumor necrosis factornuclear factor kappa Bmatrix metalloproteinasefibroblast-like synoviocytesynovial fluidMethotrexateMicroRNAMiRNAextracellular vesiclePathogenesisFAS-associated death domain proteinmonocyte chemoattractant proteinInterleukin-1 receptor-associated kinase
												Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Molecular Biology
												
											Authors
												Haitao Fu, Die Hu, Licheng Zhang, Peifu Tang, 
											